Companies gear up for conference on cancer drugs

05/28/2008 | Boston Globe (tiered subscription model), The

Genentech, Celgene and other biotech firms seeking to expand their share of the cancer drug market are preparing to present data on their experimental treatments at the American Society of Clinical Oncology's annual meeting in Chicago. Aside from Celgene's Revlimid and Genentech's Avastin, industry experts are also betting on Erbitux -- made by Merck KGaA, ImClone Systems and Bristol-Myers Squibb Co. -- to show promising trial results.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN